Published in Nat Rev Immunol on June 22, 2012
Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med (2012) 3.27
Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science (2013) 3.10
Dendritic-cell-based therapeutic cancer vaccines. Immunity (2013) 2.29
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity (2014) 2.28
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med (2015) 1.98
Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol (2013) 1.69
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons. Immunity (2016) 1.50
DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A (2013) 1.41
RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J (2014) 1.19
T follicular regulatory cells in the regulation of B cell responses. Trends Immunol (2015) 1.02
Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol (2016) 1.02
Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways. PLoS Pathog (2014) 0.97
RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. Cancer Res (2014) 0.94
Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol (2013) 0.94
Human dendritic cell subsets in vaccination. Curr Opin Immunol (2013) 0.93
Malaria modifies neonatal and early-life toll-like receptor cytokine responses. Infect Immun (2013) 0.92
Designing DNA nanodevices for compatibility with the immune system of higher organisms. Nat Nanotechnol (2015) 0.92
Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines. EBioMedicine (2016) 0.90
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines (Basel) (2013) 0.88
A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1. Genes Dev (2017) 0.87
Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy. Hum Gene Ther (2012) 0.87
DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother (2014) 0.87
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. Eur J Immunol (2015) 0.85
GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses. Nat Immunol (2013) 0.84
Fueling autoimmunity: type I interferon in autoimmune diseases. Expert Rev Clin Immunol (2013) 0.84
Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas. Cancer Gene Ther (2013) 0.84
Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors. Immunotherapy (2012) 0.84
Cell type-specific subcellular localization of phospho-TBK1 in response to cytoplasmic viral DNA. PLoS One (2013) 0.84
Innate sensing of bacterial cyclic dinucleotides: more than just STING. Nat Immunol (2012) 0.84
Type I interferon dysregulation and neurological disease. Nat Rev Neurol (2015) 0.84
Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology. Front Immunol (2013) 0.83
Targeting human dendritic cells in situ to improve vaccines. Immunol Lett (2014) 0.83
Modified mRNA Vaccines Protect against Zika Virus Infection. Cell (2017) 0.83
Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen. J Immunol (2015) 0.82
Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination. Vaccines (Basel) (2013) 0.82
Cytosolic DNA Sensor Upregulation Accompanies DNA Electrotransfer in B16.F10 Melanoma Cells. Mol Ther Nucleic Acids (2016) 0.82
Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors. Genome Biol Evol (2014) 0.82
Animal Models of Interferon Signature Positive Lupus. Front Immunol (2015) 0.81
A modified dinucleotide motif specifies tRNA recognition by TLR7. RNA (2014) 0.81
DNA vaccines: a simple DNA sensing matter? Hum Vaccin Immunother (2013) 0.81
Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP. J Nanobiotechnology (2013) 0.81
The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant. PLoS One (2013) 0.80
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen. Vaccines (Basel) (2014) 0.80
Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Hum Vaccin Immunother (2015) 0.80
MicroRNAs in the regulation of immune response against infections. J Zhejiang Univ Sci B (2013) 0.80
Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro. J Virol (2016) 0.79
NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses. Hum Vaccin Immunother (2013) 0.79
Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis. J Clin Cell Immunol (2014) 0.79
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs. Ther Adv Vaccines (2014) 0.79
Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses. J Virol (2014) 0.78
Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. BMC Cancer (2014) 0.78
Accessory Factors of Cytoplasmic Viral RNA Sensors Required for Antiviral Innate Immune Response. Front Immunol (2016) 0.78
RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine. Sci Rep (2016) 0.77
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant. Nucleic Acids Res (2015) 0.77
CEACAM1-Mediated Inhibition of Virus Production. Cell Rep (2016) 0.77
DNA degradation and its defects. Cold Spring Harb Perspect Biol (2014) 0.77
RNA-based vaccination: sending a strong message. Mol Ther (2013) 0.76
Modulating APOBEC expression enhances DNA vaccine immunogenicity. Immunol Cell Biol (2015) 0.76
Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment. Oncoimmunology (2012) 0.76
Frequency-dependent selection drives HBeAg seroconversion in chronic hepatitis B virus infection. Evol Med Public Health (2013) 0.75
Vitamin A or E and a catechin synergize as vaccine adjuvant to enhance immune responses in mice by induction of early interleukin-15 but not interleukin-1β responses. Immunology (2016) 0.75
STING-cytosolic DNA sensing: the backbone for an effective tumor radiation therapy. Ann Transl Med (2016) 0.75
Manipulation of Innate and Adaptive Immunity through Cancer Vaccines. J Immunol Res (2017) 0.75
Antiviral immunity: LGP2 rigs CD8+ T cells for survival. Nat Rev Immunol (2012) 0.75
Immune Activation in the Liver by Nucleic Acids. J Clin Transl Hepatol (2016) 0.75
Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen. PLoS One (2015) 0.75
Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7. Front Immunol (2017) 0.75
Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors. Front Immunol (2016) 0.75
Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants. Vaccine (2016) 0.75
Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice. PLoS One (2016) 0.75
Rationale for stimulator of interferon genes-targeted cancer immunotherapy. Eur J Cancer (2017) 0.75
Enhancing vaccine effectiveness with delivery technology. Curr Opin Biotechnol (2016) 0.75
TLR7 and TLR3 Sense Brucella abortus RNA to Induce Proinflammatory Cytokine Production but They Are Dispensable for Host Control of Infection. Front Immunol (2017) 0.75
Strategies and hurdles using DNA vaccines to fish. Vet Res (2014) 0.75
Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response. Radiol Oncol (2017) 0.75
IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells. PLoS One (2014) 0.75
Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities? Mol Cell Ther (2013) 0.75
DNA vaccines for prostate cancer. Pharmacol Ther (2017) 0.75
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics. J Immunother Cancer (2015) 0.75
Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promotes NF-κB Activation and Shapes a Proinflammatory Antibacterial State. Immunity (2017) 0.75
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 26.12
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Pattern recognition receptors and inflammation. Cell (2010) 21.05
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 16.65
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 16.26
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature (2009) 13.23
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24
Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol (1989) 12.08
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 11.15
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature (2009) 10.83
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature (2008) 10.73
RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell (2009) 10.11
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature (2009) 9.74
Interferon-inducible antiviral effectors. Nat Rev Immunol (2008) 9.68
Cell type-specific involvement of RIG-I in antiviral response. Immunity (2005) 9.37
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 9.16
Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A (2004) 9.00
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med (2008) 9.00
IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 8.97
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med (2001) 8.60
Regulation of adaptive immunity by the innate immune system. Science (2010) 8.00
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93
The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity (2008) 7.60
Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol (2007) 7.23
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol (2008) 7.18
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol (2009) 6.97
HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science (2009) 6.59
STING is a direct innate immune sensor of cyclic di-GMP. Nature (2011) 6.44
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature (2008) 6.40
The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 6.37
Innate recognition of viruses. Immunity (2007) 6.21
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol (2008) 6.17
Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem (2006) 5.92
Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis (2008) 5.69
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med (2008) 5.42
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol (2011) 5.34
Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature (2005) 5.32
Programming the magnitude and persistence of antibody responses with innate immunity. Nature (2011) 5.18
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity (2012) 5.08
Immune signaling by RIG-I-like receptors. Immunity (2011) 5.02
Vaccine adjuvants: putting innate immunity to work. Immunity (2010) 5.02
Intracellular toll-like receptors. Immunity (2010) 4.66
The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity (2009) 4.51
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med (2009) 4.27
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med (2006) 4.23
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med (2008) 4.21
Activation of innate immune antiviral responses by Nod2. Nat Immunol (2009) 4.19
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med (2010) 4.17
Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature (2007) 4.13
IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe (2011) 4.01
Nucleic acid recognition by the innate immune system. Annu Rev Immunol (2011) 4.00
The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect Immun (2010) 3.89
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med (2010) 3.84
Immunomodulatory functions of type I interferons. Nat Rev Immunol (2012) 3.73
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol (2009) 3.58
Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol (2009) 3.51
Dendritic cell and macrophage heterogeneity in vivo. Immunity (2011) 3.41
Immunological mechanisms of vaccination. Nat Immunol (2011) 3.35
DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity (2011) 3.01
The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol (2010) 2.95
Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature (2011) 2.93
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med (2009) 2.92
LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A (2010) 2.90
Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol (2007) 2.78
HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A (2005) 2.61
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ (2011) 2.60
An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity (2011) 2.57
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci U S A (2008) 2.57
Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol (2009) 2.47
DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med (2011) 2.41
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood (2006) 2.35
Cytosolic DNA sensors regulating type I interferon induction. Trends Immunol (2011) 2.35
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol (2003) 2.34
Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2010) 2.25
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog (2009) 2.24
Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol (2007) 2.13
Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity (2011) 2.12
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med (2011) 2.09
Regulation of the antimicrobial response by NLR proteins. Immunity (2011) 2.04
Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04
DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur J Immunol (2010) 2.03
New adjuvants for human vaccines. Curr Opin Immunol (2010) 1.98
Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog (2009) 1.92
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol (2009) 1.90
Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol (2008) 1.86
Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol (2003) 1.81
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J Clin Invest (2008) 1.74
Immunologic basis of vaccine vectors. Immunity (2010) 1.71
A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood (2008) 1.69
Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog (2009) 1.66
The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Vaccine (2010) 1.66
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood (2006) 1.65
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol (2011) 1.61
Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest (2010) 1.58
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 18.32
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol (2004) 5.71
Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol (2008) 5.10
Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med (2006) 5.01
Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat Immunol (2006) 4.15
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol (2006) 4.01
The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A (2007) 3.93
Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med (2005) 3.85
Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol (2007) 3.14
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med (2009) 2.92
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med (2005) 2.90
DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med (2011) 2.41
Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe (2010) 2.03
Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol (2008) 1.86
Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol (2003) 1.84
Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A (2012) 1.74
Pathological role of Toll-like receptor signaling in cerebral malaria. Int Immunol (2006) 1.66
Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity (2011) 1.65
Innate immune response to viral infection. Cytokine (2008) 1.63
Cutting Edge: Pivotal function of Ubc13 in thymocyte TCR signaling. J Immunol (2006) 1.60
Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol (2002) 1.48
Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med (2010) 1.46
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J Control Release (2012) 1.46
Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol (2004) 1.45
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol (2004) 1.44
DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A (2013) 1.41
Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice. Arthritis Rheum (2005) 1.40
Transcriptional regulation of the human TLR9 gene. J Immunol (2004) 1.38
TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur J Immunol (2005) 1.36
A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity. J Immunol (2011) 1.30
NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol (2011) 1.29
Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol (2008) 1.23
A critical role of IL-33 in experimental allergic rhinitis. J Allergy Clin Immunol (2012) 1.18
Enhanced TLR-mediated NF-IL6 dependent gene expression by Trib1 deficiency. J Exp Med (2007) 1.16
Effect of suppressive DNA on CpG-induced immune activation. J Immunol (2002) 1.16
Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol (2011) 1.15
Manipulation of host innate immune responses by the malaria parasite. Trends Microbiol (2007) 1.14
Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect Immun (2002) 1.13
Novel strategies to improve DNA vaccine immunogenicity. Curr Gene Ther (2011) 1.12
Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. J Immunol (2005) 1.11
Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum (2002) 1.08
CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. J Immunol (2005) 1.08
Suppressive oligonucleotides protect against collagen-induced arthritis in mice. Arthritis Rheum (2004) 1.06
Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol (2009) 1.05
Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol (2010) 1.04
CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+ monocytes. J Immunol (2005) 1.03
Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front Cell Infect Microbiol (2013) 1.01
Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis. Arthritis Rheum (2003) 1.00
Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36. Parasitol Int (2010) 0.98
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist. Proc Natl Acad Sci U S A (2014) 0.98
Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol (2006) 0.97
Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine. J Immunol (2007) 0.96
Induction of type I interferon by adenovirus-encoded small RNAs. Proc Natl Acad Sci U S A (2010) 0.95
Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol (2013) 0.94
Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax. PLoS One (2011) 0.93
The malarial metabolite hemozoin and its potential use as a vaccine adjuvant. Allergol Int (2010) 0.92
Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen. Infect Immun (2004) 0.92
Intracellular DNA sensors in immunity. Curr Opin Immunol (2008) 0.92
Fragments of genomic DNA released by injured cells activate innate immunity and suppress endocrine function in the thyroid. Endocrinology (2011) 0.92
CpG DNA: recognition by and activation of monocytes. Microbes Infect (2002) 0.92
Extrachromosomal histone H2B mediates innate antiviral immune responses induced by intracellular double-stranded DNA. J Virol (2009) 0.91
Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism. Cell Host Microbe (2012) 0.89
Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung. Crit Care Med (2004) 0.89
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice. Vaccine (2009) 0.89
Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate. Vaccine (2011) 0.88
Molecular and cellular mechanisms of DNA vaccines. Hum Vaccin (2008) 0.88
CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection. Infect Immun (2004) 0.88
Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36. PLoS One (2013) 0.85
Adjuvants in influenza vaccines. Vaccine (2012) 0.85
Contribution of interferon-beta to the immune activation induced by double-stranded DNA. Immunology (2006) 0.85
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. Eur J Immunol (2015) 0.85
Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol (2005) 0.84
Innate immune control of nucleic acid-based vaccine immunogenicity. Expert Rev Vaccines (2009) 0.83
Role of Extrachromosomal Histone H2B on Recognition of DNA Viruses and Cell Damage. Front Genet (2013) 0.83
Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice. Vaccine (2011) 0.83
Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells. J Virol (2013) 0.81
A polysaccharide carrier to effectively deliver native phosphodiester CpG DNA to antigen-presenting cells. Bioconjug Chem (2007) 0.81
Immune interventions of human diseases through toll-like receptors. Adv Exp Med Biol (2009) 0.81
A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant. J Immunol (2009) 0.80
The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant. PLoS One (2013) 0.80
Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia. J Neurochem (2013) 0.79
Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes. Infect Immun (2005) 0.79
TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine. Expert Rev Vaccines (2010) 0.79
TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models. Hum Vaccin Immunother (2013) 0.79
Type-I IFN signaling is required for the induction of antigen-specific CD8(+) T cell responses by adenovirus vector vaccine in the gut-mucosa. Biochem Biophys Res Commun (2012) 0.79
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions. Vaccine (2012) 0.78
Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier. Bioconjug Chem (2006) 0.75
[Vaccine adjuvant]. Nihon Rinsho (2011) 0.75
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children. Vaccine (2012) 0.75
Particulates Induce Type-2 Immune Responses. Nihon Eiseigaku Zasshi (2017) 0.75
Development and application of next generation SE36 malaria vaccine formulated with a novel adjuvant: approach to travelers' vaccine. Yakugaku Zasshi (2013) 0.75
Modulation of intracellular signaling using protein-transduction technology. Crit Rev Immunol (2010) 0.75